Form D · Other Technology

Pandora Bio, Inc.

Sunnyvale, CA · CIK 0001952211

Offering snapshot reported Jan 2, 2025 · SEC filing

Reported sold
$410K
Offering amount: $1M
Investors reported
18
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
May 17, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$205K$410KMay 17, 2023: $55,000.00May 17, 2023Jan 2, 2025: $410,000.00Jan 2, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$55,000 → $410,000
  • Reported investors3 → 18

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 2, 2025Amendment$410,000$355,000vs May 17, 202318SEC filing
May 17, 2023Initial$55,000No comparison3SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-481979
Simple Agreements for Future Equity (securities convertible into future capital stock upon the occurrence of certain events)

Source: Form D, filed Jan 2, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jason Carlson Director
Tara Maddala Director, Executive
Megan Rothney Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
1669 Hollenbeck Ave #199
Sunnyvale, CA, 94087